Prognostic impact of low muscle mass on clinical outcomes in patients who undergo lung transplant
- 4 April 2025
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 170 (4) , 976-985.e3
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Sarcopenia: how to measure, when and whyLa radiologia medica, 2022
- Body Composition, Inflammation, and 5-Year Outcomes in Colon CancerJAMA Network Open, 2021
- Deep neural network for automatic volumetric segmentation of whole-body CT images for body composition assessmentClinical Nutrition, 2021
- Sarcopenia measurement in research and clinical practiceEuropean Journal of Internal Medicine, 2021
- Diagnosis, prevalence, and clinical impact of sarcopenia in COPD: a systematic review and meta‐analysisJournal of Cachexia, Sarcopenia and Muscle, 2020
- Underweight Patients With Cystic Fibrosis Have Acceptable Survival Following Lung TransplantationChest, 2020
- Skeletal muscle as potential central link between sarcopenia and immune senescenceEBioMedicine, 2019
- Sarcopenia of the Psoas Muscles Is Associated With Poor Outcomes Following Lung TransplantationThe Annals of Thoracic Surgery, 2019
- Sarcopenia in lung transplantation: A systematic reviewThe Journal of Heart and Lung Transplantation, 2014
- Primary Graft Dysfunction and Long-term Pulmonary Function After Lung TransplantationThe Journal of Heart and Lung Transplantation, 2007